E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2015 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
DateTitle 
02/20/15Quest Diagnostics Earns Fortune Magazine 2015 "World's Most Admired Companies" Designation
MADISON, N.J., Feb. 20, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named a "Most Admired Company" by Fortune Magazine in the "Health Care: Pharmacy and Other Services" category. "We are proud that Quest Diagnostics is included on FORTUNE's 2015 World's Most Admired Companies list in our category," said Steve Rusckowski, President and CEO. "The honor is a true team accomplishment, and ... 
Printer Friendly Version
02/09/15Quest Diagnostics and Myriad Genetics End BRCA Patent Litigation
Agreement ensures continuing broad patient access to Quest's BRCAvantage™ services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb. 9, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.  Under the agreement, Quest Diagnostics and Myriad Genetics and its co-... 
Printer Friendly Version
01/29/15Quest Diagnostics Reports Fourth Quarter and Full Year 2014 Financial Results; Provides Guidance For Full Year 2015; Increases Dividend 15%
MADISON, N.J., Jan. 29, 2015 /PRNewswire/ -- Fourth quarter revenues from continuing operations of $1.9 billion, up 7.2% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 4.9% versus prior year Reported diluted EPS from continuing operations of $1.26, up 30% versus prior year Dividend increased 15% to $0.38 per quarter Full year 2015 revenues to grow 2% to 3% Full year 2015 adjusted diluted EPS excluding amortization expense expected to be between $4.... 
Printer Friendly Version
01/28/15Quest Diagnostics and CDC Expand Public Health Collaboration to Improve Hepatitis Diagnosis and Treatment
Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million Americans with viral hepatitis MADISON, N.J. and ATLANTA, Jan. 28, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention (CDC) to identify tre... 
Printer Friendly Version
01/13/15Quest Diagnostics To Release Fourth Quarter And Full Year 2014 Financial Results On January 29
MADISON, N.J., Jan. 13, 2015 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2014 results on Thursday, January 29, 2015, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 321... 
Printer Friendly Version
01/08/15Quest Diagnostics Names New Health Plan Leader
MADISON, N.J., Jan. 8, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the appointment of veteran health plan executive Michael Cole as vice president of health plans for Quest Diagnostics.  "We are very focused on strengthening our relationships with health plan customers," said Steve Rusckowski, president and chief executive officer, Quest Diagnostics.  "Mike has the experience and leadership to build an... 
Printer Friendly Version
01/06/15Quest Diagnostics To Speak At The 33rd Annual J.P. Morgan Healthcare Conference
MADISON, N.J., Jan. 6, 2015 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 33rd Annual J.P. Morgan Healthcare Conference in San Francisco.  Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Wednesday, January 14, 2015 at 2:30 p.m. Eastern Time. The presentation will be... 
Printer Friendly Version
01/05/15Quest Diagnostics to Speak at the Goldman Sachs Healthcare CEOs Unscripted Conference
MADISON, N.J., Jan. 5, 2015 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Goldman Sachs Healthcare CEOs Unscripted Conference in Boston.  Steve Rusckowski, the company's President and CEO, will discuss the company's vision, goals and five point strategy. The presentation is scheduled for Tuesday, January 6, 2015 at 11:00 a.m. Eastern Time. The presentation will be we... 
Printer Friendly Version